Home Office

Plymouth shooting

Chris Philp: On 12 August 2021 Jake Davison shot and killed his mother, Maxine Davison, Lee and Sophie Martin, Stephen Washington and Kate Shepherd, using his licensed shotgun. He then shot and killed himself. This was an horrific incident, and as the jury to the Inquest into these deaths returned their findings of unlawful killings yesterday afternoon, our thoughts once again go out to the families and friends of the victims, and to the whole of the local community in Keyham. It is anticipated that the Coroner will be issuing Prevention of Future Deaths reports shortly in which recommendations will be made. If, as expected, the Home Office receives a report, we will of course consider the report and recommendations very carefully and respond to the Coroner.

Ministry of Defence

Ministry of Defence Votes A  Annual Estimate 2023-24.

Mr Ben Wallace: The Ministry of Defence Votes A Estimate 2023-24, will be laid before the House on 21 February 2023 as HC 1036. This outlines the maximum numbers of personnel to be maintained for each Service in the Armed Forces during Financial Year 2023-24, including increases for Reserve Naval and Marines Forces, and a decrease for Army Regulars and Army Reserve (as well as Army Regular Reserve). Full details can be found in the publication. These numbers do not constitute the Strength of the Armed Forces, which is published separately in the UK Armed Forces Quarterly Service Personnel Statistics.Ministry of Defence Votes A Annual Estimate (pdf, 2743.0KB)

Department of Health and Social Care

NHS Hormone Replacement Therapy Prescriptions

Maria Caulfield: Around 400,000 women enter the menopause each year in the UK. Around three quarters of women will experience menopause symptoms, and around a quarter of women will experience severe symptoms. Symptoms can affect a person’s physical and mental health as well as their participation in the workplace and personal lives. Hormone Replacement Therapy (HRT) is the main treatment for menopause symptoms. Around 15% of women aged 45-64 in England are currently prescribed HRT, this has increased rapidly in the last two years from around 11% and continues to increase. To ensure that women can access the treatment they need, this Government made a commitment to reduce the cost of HRT prescriptions for menopausal women. I am pleased to announce today that from 1 April 2023 women will be able to apply for a HRT Prescription Prepayment Certificate (HRT PPC). The HRT PPC will cost the equivalent of two single prescription charges, currently £18.70 and will be valid for 12 months. The HRT PPC can be used against a list of HRT prescription items, and a patient can use this against an unlimited number of HRT items during its validity. The HRT PPC will offer savings to patients currently paying for their HRT medicines through individual charges, and for many patients the HRT PPC will also be more cost effective than a 3- or 12-month PPC if they only require HRT medicines.It is estimated that the HRT PPC will benefit approximately 400,000 patients who do not qualify for an existing prescription charge exemption. Menopause is a priority area within the Women’s Health Strategy for England. The strategy was published last summer and sets out an ambitious new agenda for improving the health and wellbeing of women and girls and improving how the health and care system listens to women. The introduction of the HRT PPC delivers one of our year one priorities for the Women’s Health Strategy for England. Reducing the cost of HRT medicines is just one part of our ongoing programme of work to improve support for menopause and access to HRT. The Government has accepted the recommendations of the HRT Taskforce, including encouraging and supporting manufacturers to boost supply to meet growing demand and continuing to issue Serious Shortages Protocols when needed. The Department closely monitors the supply of HRT and regularly meets with individual suppliers, as well as hosting quarterly roundtables with industry to ensure a continuous supply of HRT. The NHS England National Menopause Care Improvement Programme is improving clinical care for menopause and training for healthcare professionals, and we are also working across Government and with employers to improve workplace support, and boosting menopause research and evidence.

Report of the Organ Utilisation Group

Neil O'Brien: The House will remember that, under this Government, Max and Keira’s law was introduced – a law that garnered all-party support - changing the legal basis of consent for organ donation to one of deemed consent, commonly referred to as ‘opt out’. At that time the Government committed to 700 additional transplants per year which reflected the overwhelming support of the population in helping others, after their death, through the gift of organ donation. Following this legislation, the Government set up the Organ Utilisation Group (OUG) under the expert chairmanship of Professor Sir Steve Powis to deliver improvements in the number of organs that are accepted and utilised for successful transplanted in adult and paediatric patients. The House can be justly proud of the role that British clinicians and scientists have played in the history of successful transplantation. But not many realise that this leadership continues today, particularly in the field of new methods of organ preservation and perfusion. The OUG heard evidence that described the importance of continued support to maintain that leadership status both for patients in the United Kingdom and across the globe. The Government also wishes to pay tribute to patient groups, individual patients and their carers who gave time and consideration to significant engagement with the work of the OUG. It is clear the output of the report has benefited from this engagement to a significant extent. The Government welcomes the 12 recommendations in the report and note that many of these do not require extra resource; they simply need a different way of working, with increased collaboration across organisations that deliver the service. I am confident that the recommendations will give benefits to those in need of a transplant with the aim that all patients should have fair and equitable access to transplant services regardless of their background or heritage or where they live in the country. I also wish to recognise the donation and transplant teams across the country for their hard work during the pandemic. Their use of new collaborative processes have enabled people at the end of life who wished to donate to have these wishes honoured, and those patients who desperately needed a transplant to have that procedure performed, often through night-time surgery. Recommendations in the report also address the need for a robust and sustainable service that acknowledges this round-the-clock vital activity. The OUG heard evidence from national and international stakeholders, which led to the following themes and recommendations. Each recommendation is accompanied by supporting actions to inform implementation. Theme 1: Placing the patient at the heart of the serviceRecommendation 1: Patients who are being considered for transplantation, referral or listing must be supported and have equal access to services irrespective of their personal circumstances including ethnic, geographical, socio-economic status or sex.Recommendation 2: Transplant services must be run with reference to patient feedback, including frequent opportunities to listen and act on views from less heard voices. Theme 2: An operational infrastructure that maximises transplant potentialRecommendation 3: Standardised patient pathways must be developed and made available for each organ type, with well-defined timescales for each stage of the pathway. Data available for each stage of the pathway informs monitoring against best practice. Clinical Leads for Utilisation support the review of the data, to identify and drive local improvement initiatives.Recommendation 4: Transplant units must build on the lessons learned during the COVID-19 pandemic and increase further the collaborative effort across units.Recommendation 5: NHSE must undertake a comprehensive review of cardiothoracic services to ensure that services in place are sufficiently sustainable and resilient and are able to provide the best possible outcome for patients. Theme 3: Creating a sustainable workforce that is fit for the futureRecommendation 6: A National Transplant Workforce Template must be developed to provide definitions of the skill mix for an effective, safe and resilient transplant workforce that is fit for current and future demands. Theme 4: Data provision that informs decisions and drives improvementsRecommendation 7: The provision of data must be transformed, using digital approaches to provide access to complete, accurate and standardised data and information to everyone who needs it at critical decision points throughout the donation to transplantation pathway. Theme 5: Driving and supporting innovationRecommendation 8: National multi-organ centres for organ assessment and repair prior to transplantation must be established to provide the optimum practical steps to bring new techniques into everyday clinical therapy as rapidly as possible, to maximise the number and quality of organs available for transplant and support logistics at transplant units.Recommendation 9: A national oversight system must be established that makes the best use of the UK's world leading innovation in assessment, perfusion and preservation of donated organs. Theme 6: Delivering improvements through new strategic and commissioning frameworksRecommendation 10: All NHS trusts with a transplant programme must have a transplant utilisation strategy to maximise organ utilisation.Recommendation 11: National measurable outcomes must be defined and agreed in order to prioritise, monitor and evaluate the success of key strategies, tools and processes.Recommendation 12: Robust commissioning frameworks must be in place, with well-defined roles and responsibilities of the various agencies involved in organ transplantation, particularly focusing on the relationship between NHSBT and Commissioners. Memorandums of Understanding (MoUs) across the agencies must be created to formalise the process for the joint commissioning of transplant services. The Government is grateful to Professor Sir Steve Powis and all the members and observers of the OUG. We have committed to an Implementation Oversight Group that will be led by the Department of Health and Social Care, working with expert stakeholders in organ utilisation to drive forward implementation of the recommendations. The House will remember many heartfelt and emotional interventions from members across all Parties at the time when Max and Keira’s law was passed. The recommendations in this report follow up on that important change in our legislation and, once properly implemented, will increase transplants for patients in desperate need of donated organs and tissues wherever it is safe to do so.